Avantium NV operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Avantium NV with three other miscellaneous service companies in Europe: Evolva Holding SA of SWITZERLAND (2019 sales of 11.60 million Swiss Francs [US$12.66 million] of which 100% was Novel Food Nutritional & Pharmaceutical), Lysogene SA of FRANCE (13.37 million Euros [US$15.70 million] ), and Tissue Regenix Group PLC which is based in UNITED KINGDOM (£13.03 million [US$17.04 million] of which 52% was Orthopaedics).

Sales Analysis. During the year ended December of 2019, sales at Avantium NV were 13.82 million Euro (US$16.22 million). This is an increase of 22.5% versus 2018, when the company's sales were 11.28 million Euro. Sales of Renewable Chemistries saw an increase that was more than double the company's growth rate: sales were up 191.5% in 2019, from 410,000.00 Euro to 1.20 million Euro.